Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

Teruhiko Shigeoka, Masaharu Murata, Shohei Yamaguti, Takeshi Mori, Takuro Niidome, Yoshiki Katayama, Makoto Hashizume

研究成果: 会議への寄与タイプ論文

抄録

Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

元の言語英語
ページ数1
出版物ステータス出版済み - 10 19 2006
イベント55th SPSJ Annual Meeting - Nagoya, 日本
継続期間: 5 24 20065 26 2006

その他

その他55th SPSJ Annual Meeting
日本
Nagoya
期間5/24/065/26/06

Fingerprint

Liver
Magnetic resonance imaging
Molecular imaging
Imaging techniques
Molecules

All Science Journal Classification (ASJC) codes

  • Engineering(all)

これを引用

Shigeoka, T., Murata, M., Yamaguti, S., Mori, T., Niidome, T., Katayama, Y., & Hashizume, M. (2006). Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent. 論文発表場所 55th SPSJ Annual Meeting, Nagoya, 日本.

Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent. / Shigeoka, Teruhiko; Murata, Masaharu; Yamaguti, Shohei; Mori, Takeshi; Niidome, Takuro; Katayama, Yoshiki; Hashizume, Makoto.

2006. 論文発表場所 55th SPSJ Annual Meeting, Nagoya, 日本.

研究成果: 会議への寄与タイプ論文

Shigeoka, T, Murata, M, Yamaguti, S, Mori, T, Niidome, T, Katayama, Y & Hashizume, M 2006, 'Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent', 論文発表場所 55th SPSJ Annual Meeting, Nagoya, 日本, 5/24/06 - 5/26/06.
Shigeoka T, Murata M, Yamaguti S, Mori T, Niidome T, Katayama Y その他. Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent. 2006. 論文発表場所 55th SPSJ Annual Meeting, Nagoya, 日本.
Shigeoka, Teruhiko ; Murata, Masaharu ; Yamaguti, Shohei ; Mori, Takeshi ; Niidome, Takuro ; Katayama, Yoshiki ; Hashizume, Makoto. / Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent. 論文発表場所 55th SPSJ Annual Meeting, Nagoya, 日本.1 p.
@conference{934fadb7141442edad803d75ee5925e3,
title = "Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent",
abstract = "Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.",
author = "Teruhiko Shigeoka and Masaharu Murata and Shohei Yamaguti and Takeshi Mori and Takuro Niidome and Yoshiki Katayama and Makoto Hashizume",
year = "2006",
month = "10",
day = "19",
language = "English",
note = "55th SPSJ Annual Meeting ; Conference date: 24-05-2006 Through 26-05-2006",

}

TY - CONF

T1 - Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

AU - Shigeoka, Teruhiko

AU - Murata, Masaharu

AU - Yamaguti, Shohei

AU - Mori, Takeshi

AU - Niidome, Takuro

AU - Katayama, Yoshiki

AU - Hashizume, Makoto

PY - 2006/10/19

Y1 - 2006/10/19

N2 - Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

AB - Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

UR - http://www.scopus.com/inward/record.url?scp=33749845906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749845906&partnerID=8YFLogxK

M3 - Paper

AN - SCOPUS:33749845906

ER -